Metabolomic and Lipidomic Research in Diabetes and Obesity 08/07/2013

Similar documents
Rapid Lipid Profiling of Serum by Reverse Phase UPLC-Tandem Quadrupole MS

Increasing the Peak Capacity of LC/MS/MS Systems for the Analysis of Complex Biological Samples

Lipid Class Separation Using UPC 2 /MS

INTRODUCTION CH 3 CH CH 3 3. C 37 H 48 N 6 O 5 S 2, molecular weight Figure 1. The Xevo QTof MS System.

Automated Lipid Identification Using UPLC/HDMS E in Combination with SimLipid

A NOVEL METHOD OF M/Z DRIFT CORRECTION FOR OA-TOF MASS SPECTROMETERS BASED ON CONSTRUCTION OF LIBRARIES OF MATRIX COMPONENTS.

Fast Separation of Triacylglycerols in Oils using UltraPerformance Convergence Chromatography (UPC 2 )

Lipidomic Analysis by UPLC-QTOF MS

LC-Based Lipidomics Analysis on QTRAP Instruments

Mass Spectrometry based metabolomics

Applying a Novel Glycan Tagging Reagent, RapiFluor-MS, and an Integrated UPLC-FLR/QTof MS System for Low Abundant N-Glycan Analysis

Method Development for the Analysis of Endogenous Steroids Using Convergence Chromatography with Mass Spectrometric Detection

Rapid, Simple Impurity Characterization with the Xevo TQ Mass Spectrometer

New Frontiers for MS in Metabolipidomics

The Application of UPLC/MS E for the Analysis of Bile Acids in Biological Fluids

Ultra Performance Liquid Chromatography Coupled to Orthogonal Quadrupole TOF MS(MS) for Metabolite Identification

A Definitive Lipidomics Workflow for Human Plasma Utilizing Off-line Enrichment and Class Specific Separation of Phospholipids

Jose Castro-Perez, Henry Shion, Kate Yu, John Shockcor, Emma Marsden-Edwards, Jeff Goshawk Waters Corporation, Milford, MA, U.S. and Manchester, UK

Multi Omics Profiling of Methionine Restricted MCF7 Cells in 24 Hours Using a Prototype UPLC Compatible Microfluidic Device

Principles of Shotgun Lipidomics

LC/MS Method for Comprehensive Analysis of Plasma Lipids

Chemical Analysis Business Operations Waters Corporation Milford MA

O O H. Robert S. Plumb and Paul D. Rainville Waters Corporation, Milford, MA, U.S. INTRODUCTION EXPERIMENTAL. LC /MS conditions

Phospholipid characterization by a TQ-MS data based identification scheme

SelexION Technology for Lipid Analysis: Pushing the Boundaries of Lipidomics

[ APPLICATION NOTE ] APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS

Small Molecule Science: Experimental designs for achieving ultra trace analysis

Andrea Perissi Specialista Applicativo, Waters Italia Waters Corporation 1

Supplementary Information

Thermo Scientific LipidSearch Software for Lipidomics Workflows. Automated Identification and Relative. Quantitation of Lipids by LC/MS

Lipididentifizierung in der LC-MS-basierten Lipidomik mittels einer Kombination aus SWATH und DMS

[ APPLICATION NOTE ] High Sensitivity Intact Monoclonal Antibody (mab) HRMS Quantification APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS

Quantitation of Sphingolipids in Tissue Extracts by LC/MS/MS

Profiling Flavonoid Isomers in Highly Complex Citrus Juice Samples Using UPLC Ion Mobility Time-of-Flight Mass Spectrometry

Lipids Analysis. Lipids

A UPLC/MS Approach for the Diagnosis of Inborn Errors of Metabolism

Data Independent MALDI Imaging HDMS E for Visualization and Identification of Lipids Directly from a Single Tissue Section

The use of mass spectrometry in lipidomics. Outlines

Supporting Information

Mass-Spectrometric Analysis of Lipids (Lipidomics)

SUPPLEMENTARY DATA. Materials and Methods

Sample Preparation is Key

Supporting information

Removal of Triton X-100 from Plasma Samples Using Mixed-Mode Solid Phase Extraction (SPE)

Metabolomics Core Lab School of Medicine University of Utah

Impact of Chromatography on Lipid Profiling of Liver Tissue Extracts

Supporting Information (SI)

UPLC-MS/MS Analysis of Azole Antifungals in Serum for Clinical Research

Multiple Reaction Monitoring for Direct Quantitation of Intact Proteins using a Triple Quadrupole Mass Spectrometer

Latest Innovations in LC/MS/MS from Waters for Metabolism and Bioanalytical Applications

Glycerolipid Analysis. LC/MS/MS Analytical Services

PosterREPRINT RAPID, SELECTIVE SCREENING OF URINE SAMPLES FOR GLUCURONIDES BY LC/MS/MS INTRODUCTION ABSTRACT

Obtaining Answers to Biological Questions Sample Prep to Data Analysis. Jeremiah D. Tipton, Ph.D. SCIEX Advanced Workflow Specialist in OMICS

LC/MS/MS SOLUTIONS FOR LIPIDOMICS. Biomarker and Omics Solutions FOR DISCOVERY AND TARGETED LIPIDOMICS

Comprehensive Two-Dimensional HPLC and Informative Data Processing for Pharmaceuticals and Lipids

CHARACTERIZATION AND DETECTION OF OLIVE OIL ADULTERATIONS USING CHEMOMETRICS

[ application note note ] ]

Mechanistic Insight into Oxidized N,N-Dimethylacetamide as a source of Formaldehyde Related Process Derivatives

Enrichment of Phospholipids from Biological Matrices with Zirconium Oxide-Modified Silica Sorbents

MASS SPECTROMETRY BASED METABOLOMICS. Pavel Aronov. ABRF2010 Metabolomics Research Group March 21, 2010

Analysis of Testosterone, Androstenedione, and Dehydroepiandrosterone Sulfate in Serum for Clinical Research

Increased Identification Coverage and Throughput for Complex Lipidomes

Simple Method (IS-MRM) to Monitor Lysophospholipids and Phospholipids During LC-MS Method Development via In-Source CID

[application note] DIRECT TISSUE IMAGING AND CHARACTERIZATION OF PHOSPHOLIPIDS USING A MALDI SYNAPT HDMS SYSTEM

Development of a Bioanalytical Method for Quantification of Amyloid Beta Peptides in Cerebrospinal Fluid

Metabolomics and Lipidomics Approaches for Biomedical Research and Biomarker Discovery

Quantitative Analysis of Drugs of Abuse in Urine using UHPLC Coupled to Accurate Mass AxION 2 TOF Mass Spectrometer

High resolution mass spectrometry for bioanalysis at Janssen. Current experiences and future perspectives

John Haselden 1, Gordon Dear 1, Jennifer H. Granger 2, and Robert S. Plumb 2. 1GlaxoSmithKline, Ware, UK; 2 Waters Corporation, Milford, MA, USA

Metabolomic and Proteomics Solutions for Integrated Biology. Christine Miller Omics Market Manager ASMS 2015

CEU MASS MEDIATOR USER'S MANUAL Version 2.0, 31 st July 2017

Achieve Broad Lipid Quantitation using a High-Throughput Targeted Lipidomics Method

Quantification of PtdInsP 3 molecular species in cells and tissues by mass spectrometry

A Metabolomics Approach to Profile Novel Chemical Markers for Identification and Authentification of Terminalia Species

Lipid Analysis. Andréina Laffargue, IRD CRYMCEPT Montpellier workshop, October 17th Introduction to lipid structures

Targeted and untargeted metabolic profiling by incorporating scanning FAIMS into LC-MS. Kayleigh Arthur

Dr. Erin E. Chambers Waters Corporation. Presented by Dr. Diego Rodriguez Cabaleiro Waters Europe Waters Corporation 1

Increasing Molecular Coverage in Complex Biological and Environmental Samples by Using IMS-MS

Ozonolysis of phospholipid double bonds during electrospray. ionization: a new tool for structure determination

Metabolomic fingerprinting of serum samples by direct infusion mass spectrometry

Introduction. Robert S. Plumb 1, *, Michael D. Jones 2, Paul D. Rainville 2, and Jeremy K. Nicholson 1 1. Abstract

Supplementary Information. Effects of Perfluorooctanoic Acid on Metabolic Profiles in Brain and Liver of Mouse by a

Profiling of Endogenous Metabolites Using Time-of-Flight LC/MS with Ion Pair Reverse Phase Chromatography

High-Resolution Analysis of Intact Triglycerides by Reversed Phase HPLC Using the Agilent 1290 Infinity LC UHPLC System

SUPPORTING INFORMATION:

The use of mobile-device data to better estimate dynamic population size for wastewater-based epidemiology

Supporting Information. Scale-up synthesis of tesirine

Analysis of N-Linked Glycans from Coagulation Factor IX, Recombinant and Plasma Derived, Using HILIC UPLC/FLR/QTof MS

Bioanalytical Quantitation of Biotherapeutics Using Intact Protein vs. Proteolytic Peptides by LC-HR/AM on a Q Exactive MS

UPLC/MS Monitoring of Water-Soluble Vitamin Bs in Cell Culture Media in Minutes

MS/MS as an LC Detector for the Screening of Drugs and Their Metabolites in Race Horse Urine

OMCL Network of the Council of Europe QUALITY MANAGEMENT DOCUMENT

Identification of Haemoglobinopathies by LC/MS

1. Sample Introduction to MS Systems:

LC-MS/MS for the quantification of Peptide biomarker and mixture of closely related Protein in formulation

SWATH Acquisition Enables the Ultra-Fast and Accurate Determination of Novel Synthetic Opioids

Automated Purification and Analytical Reinjection of a Small Molecule Drug, Probenecid, on a Gilson LC/MS Dual Function System

LCMS-8030 Application Report. Steroids: Testosterone, Progesterone, Estradiol, Ethinylestradiol

Reduced Ion Suppression and Improved LC/MS Sensitivity with Agilent Bond Elut Plexa

Direct Analysis of Folic Acid in Digestive Juices by LC/TOF-MS Application

Transcription:

Novel Tools for omics -based Analysis of Complex Mixtures; Application to a Investigation of the Effect of Prolonged Glucose Stimulation on the Lipid Profile of Mouse Heart Muscle John P. Shockcor, PhD, FRSC CChem Director of Strategic Operations, Pharmaceutical and Life Sciences, Waters Corp. Professor, Dept. Of Surgery and Cancer, Imperial College, London, UK Visiting Fellow, Dept. of Biochemistry, University of Cambridge, UK 2012 Waters Corporation 1 Metabolomic and Lipidomic Research in Diabetes and Obesity Prof. Jules Griffin, MRC HNR & University of Cambridge Dr.Helen Atherton Dr.Melanie Gulston 1

Effect of insulin on glucose uptake and metabolism. Insulin binds to its receptor (1) which in turn starts many protein activation cascades (2). These include: translocation of Glut-4 transporter to the plasma membrane and influx of glucose (3), glycogen synthesis (4), glycolysis (5) and fatty acid synthesis (6). 2012 Waters Corporation 3 The Diabetic Heart Type II diabetes is characterized by insulin resistance, and in the heart this results in a failure to recruit Glucose Transporter 4 (GluT4) into the cell membrane during periods of high blood glucose. As a result, metabolism of the diabetic heart has an increased reliance on beta-oxidation of fatty acids. This has been linked to the increased lipid load which may result in lipotoxicity in the diabetic heart. In addition the ATP generated by fatty acid oxidation requires more oxygen compared with that derived from the oxidation of glucose, increasing the risk of ischaemic heart disease. 2012 Waters Corporation 4 2

Study Description In this study we have examined a mouse model where Glucose Transporter 1 has been increased in expression selectively in the heart. GLUT1 is responsible for the low-level of basal glucose transport. It is a non-insulin dependent glucose transporter and as such it will dramatically increase glucose metabolism in the heart. 2012 Waters Corporation 5 Study Description Wild-type and transgenic mice were sacrificed at 3 months and the heart tissue rapidly dissected and stored at -80C. A chloroform/methanol extraction was performed and the lipids in the organic layer for all samples were profiled using a UPLC/Synapt G2. 2012 Waters Corporation 6 3

Question? What is the effect of prolonged glucose stimulation on the lipid profile of heart tissue? 2012 Waters Corporation 7 Intact Lipid Analysis: 2012 Waters Corporation 8 4

Chromatography 2012 Waters Corporation 9 Direct Infusion of a Tissue Extract 2012 Waters Corporation 10 5

Exapnded Region around m/z 806 PC 38:6 2012 Waters Corporation 11 TIC of Tissue Extract 2012 Waters Corporation 12 6

TIC and XIC for m/z 806.5695 PC 38:6 PC 16:0/22:6 Isotope of 804 PC 18:2/20:4 2012 Waters Corporation 13 UPLC and MS Conditions for Global Lipid Profiling 2012 Waters Corporation 14 7

UPLC/MS from liver extract PC, PG, PE ChoE & TG lysophospolipids SM, DG FFA PG,PI, PS, PE 2012 Waters Corporation 15 Trizaic 2012 Waters Corporation 16 8

TRIZAIC UPLC System 2012 Waters Corporation 17 nanotile Flow Path 2012 Waters Corporation 18 9

Free Fatty Acids 18:0 18:1 16:0 18:2 20:4 22:6 18:3 Linear response between 0.015 ng/ l and 5 ng/ l Mobile phase A: ACN/Water (60:40) with 10 mm NH 4 formate and 0.1% FA Mobile phase B: IPA/ACN (90:10) with 10 mm NH 4 formate and 0.1% FA 2012 Waters Corporation 19 Liver Extract: Positive Ion Mode Column: CSH C18, 0.15 x 100 mm TG PC, SM, PE, PG, PI LP 2012 Waters Corporation 20 10

Total Lipids Extract from Liver Negative Ionization mode PC, SM, PE, PG, PI FFA, LP 2012 Waters Corporation 21 Tic of Human Urine (Positive Ion) 2012 Waters Corporation 22 11

UPC 2 2012 Waters Corporation 23 UPC 2 Free Fatty Acid FFA Mix 1 FFA Method 0.5ul inj 15CV0 17:14:13 TAGs_08022012_026 100 % C14:0 1.05 227.1970 C16:0 1.18 255.2276 C18:0 1.35 283.2587 C20:0 1.52 311.2894 C22:0 1.72 339.3196 C24:0 1.93 367.3502 Method Conditions: 03-Aug-2012 1: TOF MS ES- BPI Instrument: 1.71e5 ACQUITY UPC 2 Column: ACQUITY UPC 2 HSS C 18 SB Co-solvent: MeOH w/ 2g/L Ammonium Formate Gradient: 1 to 10% over 5 minutes* Flow: 2.5 ml/min Temperature: 60 0 C CCM Pressure: 1885 Injection Vol: 0.5uL Make-up flow: 0.2mL/min of 0.1% formic acid Splitter: Upchurch cross 1/16 PEEK C12:0 0.91 199.1659 Sample Concentration: 0.25mg/mL FFA: C8 to C24 0 C8:0 C10:0 0.79 171.1348 Time 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 2.00 2.20 2.40 2.60 2.80 2012 Waters Corporation 24 12

UPC 2 /oa-qtof: 2012 Waters Corporation 25 MS Analysis 2012 Waters Corporation 26 13

Electro-Spray Ionization 2012 Waters Corporation 27 A Quadrupole Time-of Flight Mass Spectrometer 2012 Waters Corporation 28 14

Fragmentation of a Typical Glycerophospholipid O sn-1-h20 O sn-1 P R 1 O O O HO R 2 O H sn-2-h20 N + O sn-2 Phosphotadylcholine (PC) 2012 Waters Corporation 29 Fragmentation of Triglycerides sn-2-nl NL sn-1 O sn-1-nl NL sn-3 O R 1 O R 2 O R 3 O H O sn-2 sn-3-nl Note: The fragmentation for Mono and Di Glycerides cleaves the same bonds. 2012 Waters Corporation 30 15

UPLC/MS E (Step 1) 2012 Waters Corporation 31 UPLC/MS E ( low energy) Co-Eluting Ions Ionized Precursors Precursors Transferred to TOF MS 2012 Waters Corporation 32 16

UPLC/MS E (high energy) Co-Eluting Ions Ionized Precursors Precursors & Products Transferred to TOF-MS 2012 Waters Corporation 33 UPLC/HDMS E (low energy) deconvoluting chimericy Co-Eluting Ions Ionized Precursors Precursors IMS Separated Precursors Transferred to TOF MS 2012 Waters Corporation 34 17

UPLC/HDMS E (high energy) deconvoluting chimericy Co-Eluting Ions Ionized Precursors Precursors IMS Separated Precursors & Products Time Aligned 2012 Waters Corporation 35 UPLC/HDMS E 2012 Waters Corporation 36 18

Fragmentation Spectrum of TG (18:0/18:1/18:1) m/z 904.8333 2012 Waters Corporation 37 Export to EZinfo 2012 Waters Corporation 38 19

PLS-DA of All Groups 2012 Waters Corporation 39 Transfer of Loadings 2012 Waters Corporation 40 20

Tagging Imported Loadings 2012 Waters Corporation 41 Creating a Filter 2012 Waters Corporation 42 21

Working with Selected Compounds Mined from MVA 2012 Waters Corporation 43 Acknowledgements Waters Corporation Milford, USA Scot Germanos Giorgis Issac Andy Baker Waters Corporation Manchester, UK James Langridge Mike Morris John Hoyes Martin Green Jason Wildgoose Kevin Giles Steve Pringle Ronan O Malley Alistair Wallace Jeff Goshawk Richard Gilpin 2012 Waters Corporation 44 22

Acknowledgements University Of Cambridge Cambridge, UK Jules Griffin Helen Atherton Melanie Gulston Imperial College London, UK Jeremy Nicholson Elaine Holmes Liz Want Matt Lewis Merck USA Jose Castro Perez 2012 Waters Corporation 45 Acknowledgements 2012 Waters Corporation 46 23